Open AccessOctreotide treatment in a neonate with non-chylous pleural effusion
Author(s) -
Salih Kalay,
Osman Öztekin,
Gönül Tezel,
Burak Emre Demir,
Mustafa Akçakuş,
Nihal Oygür
Publication year - 2013
Publication title -
african journal of paediatric surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.163
H-Index - 17
eISSN - 0189-6725
pISSN - 0974-5998
DOI - 10.4103/0189-6725.125452
Subject(s) - medicine , thoracentesis , octreotide , chylothorax , pleural effusion , pleurodesis , chylous ascites , thoracostomy , surgery , effusion , ascites , somatostatin , pneumothorax
Fetal pleural effusion is a rare condition. While it may regress spontaneously, it may also continue up to the post-natal period. This condition may be treated by thoracentesis, thoracoabdominal shunt application and pleurodesis in the intrauterine period while thoracentesis or tube thoracostomy may be used in the post-natal period. In cases where the fluid is defined to represent chylothorax, octreotide, a somatostatin analogue, may be administered for treatment. In this case report, we discussed the outcomes of treatment with octreotide administered in a neonatal case under follow-up due to fetal pleural effusion and with non-chylous ascites detected in the post-natal period.